torsdag 15. desember 2022
Registration og coffee
We will welcome you at our DNB's head office.
Adress:
Dronning Eufemias gate 30
0191 Oslo
NORWAY
DNB NXT Healthcare Venture Session & DNB Healthcare Prize 2022
11 companies are selected by a professional jury to present at the DNB NXT Healthcare Venture Session. They will all be awarded with having their logos displayed on Nasdaq’s boards on Times Square. The winner of the DNB Healthcare Prize 2022 will get an extended profiling on the Nasdaq boards.
Kl. 08:00
Welcome
Rasmus Figenschou, Executive Vice President DNB
Kl. 08:05
Opening of DNB NXT Healthcare Venture Session 2022
Lena Nymo Helli
CEO Norway Health Tech
Company 1 I Adjutec Pharma AS
Company 2 I Arxx Therapeutics
Company 3 I Bulbitech AS
Company 4 I ClexBio
Company 5 I Helseapps
Company 6 I Hemispherian AS
10:35 Break
Kl. 09:45
Key Note Speaker | Róbert Wessman
CEO & Chairman Alvotec
Róbert is the founder and Executive Chairman of Alvotech. He is also the founder and Chairman of Alvogen,
Chairman of Lotus Pharmaceuticals and serves as a board member at Fuji Pharma Co. Ltd. Previously,
Mr. Wessman as CEO led Actavis from 1999 - 2008, transforming it into a leading global generics company.
Kl. 10:05
DNB NXT Healthcare Venture Session 2022 Continues
Company 7 I Kongsberg Beam Technology AS
Company 8 I Oncosyne
Kl. 10:35
Voting and selection of the 4th finalist
How do we vote
Kl. 12:05 Lunch
Kl. 11:45
Introduction to the DNB Healthcare Finals 2022
Ketil Widerberg
CEO Oslo Cancer Cluster
Finalist 1 I Domore Diagnostics
Finalist 2 I NaDeNo Nanoscience AS
Finalist 3 I Thelper
Finalist 4 I Will be selected at the conference
Voting for the winner of the DNB Healthcare Prize 2022
Kl. 13:00
Announcement of the winner of the DNB Healthcare Prize 2022
Trine Loe, Executive Vice President DNB
Award from Nasdaq I Carsten Borring, Head of Listings & Capital Markets Nasdaq
14:30 Closure
DNB Markets Sessions - Auditorium 2
Preliminary Agenda
Kl. 08:00
Companies part 1
Photocure | Dan Schneider, CEO
Vicore Pharma | Carl-Johan Dalsaard, CEO
Xbrane Biopharma | Martin Åmark, CEO
Vitrolife | Patrik Tolf, CFO
10:35 Break
Kl. 09:45
Key Note Speaker | Róbert Wessman
CEO & Chairman Alvotec
Róbert is the founder and Executive Chairman of Alvotech. He is also the founder and Chairman of Alvogen,
Chairman of Lotus Pharmaceuticals and serves as a board member at Fuji Pharma Co. Ltd. Previously,
Mr. Wessman as CEO led Actavis from 1999 - 2008, transforming it into a leading global generics company.
Kl. 09:55
Companies part 2
Elekta | Tobias Hägglöv, CFO
BioArctic | Gunilla Osswald, CEO
Alvotech | Róbert Wessman, Founder & Chairman
Kl. 12:05 Lunch
Kl. 11:35
Companies part 3
Camurus | Fredrik Tiberg, CEO
Oncopeptides | Sofia Heigis, CCO & Fredrik Schjesvold, MD, PhD Head of Myeloma Center Oslo University Hospital
Alligator Bioscience | Søren Bregenholt, CEO
Surgical Science | Gisli Hennermark, CEO & Anna Ahlberg, CFO
14.10 Break
Kl. 13:10
Companies part 4
Nykode Therapeutics | Michael Engsig, CEO
Ultimovacs | Carlos de Sousa, CEO
Targovax | Erik Digman Wiklund, CEO
Observe Medical | Rune Nystad, CEO
15:55 Closure
DNB Markets Sessions - Auditorium 3
Kl. 08:00
Companies part 1
IrLAB | Richard Godfrey, CEO
Medistim | Kari Krogstad, CEO
Bonesupport | Emil Billbäck, CEO
Arctic Bioscience | Christer Valderhaug, CEO
10:35 Break
Kl. 09:45
Key Note Speaker | Róbert Wessman
CEO & Chairman Alvotec
Róbert is the founder and Executive Chairman of Alvotech. He is also the founder and Chairman of Alvogen,
Chairman of Lotus Pharmaceuticals and serves as a board member at Fuji Pharma Co. Ltd. Previously,
Mr. Wessman as CEO led Actavis from 1999 - 2008, transforming it into a leading global generics company.
Kl. 09:55
Companies part 2
BioInvent | Martin Olin, CEO
Hansa Biopharma | Klaus Sindahl, Head of IR
BerGenBio | Martin Olin, CEO
Kl. 12:05 Lunch
Kl. 11:35
Companies part 3
SoftOx | Geir Almås, CEO
Gentian Diagnostics | Hilja Ibert, CEO
Nanoform | Edward Hæggström, CEO
Exact Therapeutics | Per Walday, CEO
14.10 Break
Kl. 13:20
Companies part 4
Sedana Medical | Johannes Doll,CEO
Cantargia | Göran Forsberg, CEO
Navamedic | Kathrine Gamborg Andreassen, CEO
15:30 Closure
DNB Markets Sessions - Room C-2
Kl. 08:50
Private Companies session
Oncoinvent | Jan Alfheim, CEO
AP3 Biomedical | David Rosén, CEO
10:35 Break
Kl. 09:45
Key Note Speaker | Róbert Wessman
CEO & Chairman Alvotec
Róbert is the founder and Executive Chairman of Alvotech. He is also the founder and Chairman of Alvogen,
Chairman of Lotus Pharmaceuticals and serves as a board member at Fuji Pharma Co. Ltd. Previously,
Mr. Wessman as CEO led Actavis from 1999 - 2008, transforming it into a leading global generics company.
Kl. 09:55
Private Companies session continues
Cytovation | Lars Prestegarden, CEO
Domore Diagnostics | Torbjørn Furuseth,CEO
Sigrid Therapeutics | Sana Alajmovic, CEO
Kl. 12:05 Lunch
Kl. 11:35
Private Companies session last part
Zelluna Immunotheraphy | Namir Hassan, CEO
12:55 Closure